Pharmaceutical Industry: 2025 Results and Key Trends for 2026
On 21 January 2026, REVERA law group, together with its partners—PharmAssistance, 103.by, Kesarev and SMARTDOCTOR—held an online webinar dedicated to the results of 2025 and the key trends shaping the development of the pharmaceutical industry in 2026.
| This is an industry webinar focused on the current changes and prospects for the development of the Life Science market. The event centred on the transformation of pharmaceutical legislation, the dynamics of online sales of pharmacy goods, the development of common EAEU markets, changes in medicinal product registration procedures, as well as modern formats of professional training in the sector. |
The webinar participants—leading experts and market practitioners—presented analytical reviews, legal commentary and practical case studies that will be useful for medicinal product manufacturers, distributors, pharmacy chains, regulatory affairs professionals, lawyers and representatives of educational projects in the Life Science sector.
The event moderator was Sergei Sushchenya, Head of the Life Science Practice at REVERA law group.
Key programme topics covered at the event
- Online sales of pharmacy goods: market overview and analytics based on digitised data
Experts from 103.by presented an analysis of the current state of the online pharmacy goods market, key growth indicators and the role of data in business decision-making. Participants learned where the strongest momentum is observed.
- Pharmaceutical market legislation: key changes in 2025, expected innovations and legal trends for 2026
REVERA law group lawyers—Sergei Sushchenya, Head of the Life Science Practice, and Denis Valiukevich, Senior Associate in the Life Science Practice—spoke about the most significant changes to pharmaceutical market regulation that entered into force in 2025, as well as legislative initiatives and legal trends that may affect market participants’ activities in 2026. Particular attention was paid to risks and practical recommendations for business.
- Medicinal product registration: legislative innovations—old challenges, new opportunities
Alexander Matyushyonok, CRO expert at PharmAssistance, outlined changes in medicinal product registration procedures, current regulatory requirements and potential difficulties faced by applicants. The presentation also addressed new opportunities opening up for manufacturers and marketing authorisation holders.
- Common EAEU Life Science markets: current status and directions for development
Rinat Galitdinov, Senior Adviser at Kesarev, presented an overview of the current state of the common EAEU markets in Life Science, as well as prospects regarding regulation and the expansion of companies’ presence in the Union’s markets.
- Educational projects in Life Science: modern formats and approaches
In discussing educational initiatives, Ekaterina Lisitsina, Chief Operating Officer of the SMARTDOCTOR training platform for doctors, reviewed and presented modern learning formats, digital tools and new approaches to training specialists in Life Science, taking into account market needs and regulatory changes.
And, of course, the event concluded with a participant Q&A session, during which attendees put practical questions to the experts and discussed the topics most relevant to them.
|
The webinar provided a platform for professional dialogue and the exchange of expertise, and enabled participants to gain a holistic view of the key changes and trends shaping the future of the Life Science sector. |
We thank all participants for the lively discussion, engagement and interest in the topic.
We are confident that the insights gained will serve as a valuable basis for strategic decisions in the coming year.
If you are not yet subscribed to our social media channels, please do subscribe so you do not miss event announcements and are the first to receive useful guides and reviews.
- Telegram: REVERA Belarus
- Telegram: REVERA for TECH
- Telegram: Life Science by REVERA
- LinkedIn: REVERA law group
Materials are protected by copyright.
Publication of information from the presentations is possible subject to agreement with the organiser.
Contact a lawyer for further information
Contact a lawyer
